Loading quotes...

Forecast

The analysts' average price target is €10.31 (+872.64%). The median is €10.31 (+872.64%).

Buy	3
Hold	1
Sell	0

News Go to news feed

Cibus misses Q2 revenue forecast; shares fall 16% after hours

Cibus reported Q2 2026 revenue of $1.0 million versus a $1.75 million analysts’ expectation, after which the stock fell about 15.8% in after‑hours trading. The company also reported significant cost reductions, a reduced net loss of $22.1 million and cash of $20.4 million. Management raised its forecast for net cash burn through the end of 2026 to around $35 million, and expects the financial runway to extend into early Q1 2027. The company noted commercial progress on sustainable ingredients, while rice license revenues are expected to be realized only in 2028/2029 due to timing shifts. » More on de.investing.com

Financials

In the last quarter, CIBUS INC had revenue of €870.95k and net profit of -€19.4m

(EUR)	June 2026	YoY
Revenue	870.95k	10.03%
Gross profit	-147.2k	118.60%
Net profit	-19.4m	9.86%
EBITDA	-10.08m	27.07%

Fundamentals

Metric	Value
Market capitalization	€78.14m
Number of shares	76.43m
52-week high/low	€3.76 - €0.98
Dividends	No
Beta	1.64
P/E ratio	-0.69
PEG ratio	0.00
P/B ratio	5.91
P/S ratio	20.04

Company profile

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.